Literature DB >> 7774682

Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.

D M Helmeste1, S W Tang, C Reist, R Vu.   

Abstract

The serotonin uptake inhibitors sertraline, paroxetine and fluoxetine were compared with imipramine and the calmodulin antagonists N-(6-aminohexyl)-5-chloro-1-naphthalene-sulfonamide (W-7) and calmidazolium, for their effects on intracellular Ca2+ mobilization in human platelets. All serotonin uptake inhibitors and calmodulin antagonists augmented thrombin-mediated increases in intracellular Ca2+. Sertraline, calmidazolium and W-7 also caused large dose-dependent increases in baseline levels of intracellular Ca2+. There was a rough correlation between the ability to elevate intracellular Ca2+ and potencies for inhibition of calmodulin. Neomycin, an inhibitor of inositol trisphosphate (IP3) generation, significantly inhibited the effects of sertaline. This is consistent with a role of IP3 and calmodulin in the effects of these drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774682     DOI: 10.1016/0922-4106(95)90051-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Ca2+-mediated potentiation of the swelling-induced taurine efflux from HeLa cells: on the role of calmodulin and novel protein kinase C isoforms.

Authors:  B Falktoft; I H Lambert
Journal:  J Membr Biol       Date:  2004-09-15       Impact factor: 1.843

2.  Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Authors:  Lars Wöckel; Florian Daniel Zepf; Sabrina Koch; Anikó-Eva Meyer-Keitel; Martin H Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

Review 3.  Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis.

Authors:  Krishna Undela; Gurumurthy Parthasarathi; Sharon Sunny John
Journal:  Indian J Pharmacol       Date:  2015 May-Jun       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.